Changing Compliance to Change the Game: IVL for Transfemoral EVAR/TEVAR Access
Frank Arko, MD, Chief of Vascular and Endovascular Surgery, Sanger Heart and Vascular Institute, Atrium Health, Charlotte, North Carolina
In this interview, Frank Arko, MD, Chief of Vascular and Endovascular Surgery at Sanger Heart and Vascular Institute, Atrium Health discusses his use of IVL to maintain transfemoral EVAR/TEVAR access in patients with calcified vessels. Dr. Arko reviews the Shockwave PAD III RCT data including recently published 1- and 2-year results, as well as the results of the Shockwave PAD OS iliac cohort. Dr. Arko then shares a case example of how IVL allowed him to use transfemoral access in a patient with calcified iliac and CFA disease.
About Us
Vascular Disease Management™ (VDM), the official media partner of the International Symposium on Endovascular Therapy (ISET) and the Amputation Prevention Symposium (AMP), is a peer-reviewed journal that educates readers on the latest advancements in endovascular treatment strategies.
Learn more about ISET and AMP and register for the events here:




